China has become the preferred place for Asian pharmaceutical research and development outsourcing
Release time: 2010-01-15 & nbsp & nbsp & nbsp Source:
Mainland China Pharmaceutical stake betting appStake Sports BettingR & D enterprise has more than 400 companies，Due to the rich talent resources、Infrastructure improvement and government policy support，At present, it has surpassed India to become the preferred place for Asian pharmaceutical research and development outsourcing。This is the latest information disclosed by Kang Longhua's chairman of the company today。
Lou Bailiang said at the conference of the acquisition of "Weitong Boji (China)" held here，Pharmaceutical R & D service as a modern new industry with high -tech content and added value，To absorb talents、Development regional economy、improving the industrial structure has a promotion role，Get strong support from local governments，Show accelerating the development trend。
The statistics he provided shows: The current cost of new drug development in the world exceeds one billion US dollars，and Stake Sports Bettingthe pharmaceutical outsourcing stake sports betting appmarket increased at a rate of more than 20 % each year，This year will exceed 30 billion US dollars。To improve research and development efficiency，Many pharmaceutical companies outsourcing the research and development work to developing countries，Make pharmaceutical research and development outsourcing becomes the second largest outsourcing industry after software outsourcing services。Also one -third of China's pharmaceutical research and development outsourcing enterprises are concentrated in Beijing，The annual income of Beijing Biomedical R & D service last year has exceeded RMB 5 billion。
Established in 2003 years, Kang Longhuangcheng Company with pharmaceuticals、Biotechnology companies and academics and government agencies as service objects，Provide new drug discovery、Clinical New Pharmaceutical Laboratory and Comprehensive Service。Stake Sports BettingMy stake betting appAfter completing the acquisition of Weitong Boji，Kang Longhua's company owns chemistry、Pharmacology、Bio、Nine hundred professional researchers in the fields of drug metabolism and dynamics and process development，Become the first in Mainland China to record at the United States Food and Drug Administration and the European Drug Administration at the same time，R & D outsourcing institutions that have all technologies such as from drug discovery to clinical trials。
Lou Bailiang said at the conference of the acquisition of "Weitong Boji (China)" held here，Pharmaceutical R & D service as a modern new industry with high -tech content and added value，To absorb talents、Development regional economy、improving the industrial structure has a promotion role，Get strong support from local governments，Show accelerating the development trend。
The statistics he provided shows: The current cost of new drug development in the world exceeds one billion US dollars，and Stake Sports Bettingthe pharmaceutical outsourcing stake sports betting appmarket increased at a rate of more than 20 % each year，This year will exceed 30 billion US dollars。To improve research and development efficiency，Many pharmaceutical companies outsourcing the research and development work to developing countries，Make pharmaceutical research and development outsourcing becomes the second largest outsourcing industry after software outsourcing services。Also one -third of China's pharmaceutical research and development outsourcing enterprises are concentrated in Beijing，The annual income of Beijing Biomedical R & D service last year has exceeded RMB 5 billion。
Established in 2003 years, Kang Longhuangcheng Company with pharmaceuticals、Biotechnology companies and academics and government agencies as service objects，Provide new drug discovery、Clinical New Pharmaceutical Laboratory and Comprehensive Service。Stake Sports BettingMy stake betting appAfter completing the acquisition of Weitong Boji，Kang Longhua's company owns chemistry、Pharmacology、Bio、Nine hundred professional researchers in the fields of drug metabolism and dynamics and process development，Become the first in Mainland China to record at the United States Food and Drug Administration and the European Drug Administration at the same time，R & D outsourcing institutions that have all technologies such as from drug discovery to clinical trials。
